Drug Type Small molecule drug |
Synonyms 叶酸/胆钙化醇/钴胺素/柠檬酸钙, 칼시큐정 |
Action modulators, stimulants, agonists |
Mechanism Folate receptor modulators, MUT stimulants(Methylmalonyl-CoA Mutase stimulants), VDR agonists(Vitamin D receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (19 Aug 2024), |
Regulation- |
Molecular FormulaC63H88CoN14O14P |
InChIKeyDLRXOSFAWIKARM-SYUKHSAKSA-M |
CAS Registry68-19-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Developmental Disabilities | South Korea | 19 Aug 2024 | |
Rickets | South Korea | 19 Aug 2024 |